• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[玻璃体在糖尿病视网膜病变中的作用]

[Role of the vitreous body in diabetic retinopathy].

作者信息

Hendrikse F, Yeo K T

机构信息

Klinik für Augenheilkunde Academisch ziekenhuis Maastricht.

出版信息

Klin Monbl Augenheilkd. 1993 Nov;203(5):319-23. doi: 10.1055/s-2008-1045684.

DOI:10.1055/s-2008-1045684
PMID:8114473
Abstract

UNLABELLED

In recent years it has become evident that the vitreous must play a role in various aspects of diabetic retinopathy. The exact role of the vitreous is however in many aspects still ill defined. There are structural changes of the vitreous, as for instance vitreous liquefaction and posterior vitreous detachment, that are associated with the occurrence and earlier onset of diabetic retinopathy. Further there are angiogenic and angioinhibitory factors in the vitreous which influence neovascularisation by means of endothelial cell proliferation. Photocoagulation of the retina can cause structural changes (posterior vitreal detachment) and histological changes (increased hyalocytes activity) which can protect against the progression of proliferative diabetic retinopathy. The role of vitrectomy in protecting against proliferative diabetic retinopathy is generally concerned to be related to the removal of the vitreal scaffold. But vitrectomy can also induce changes in the oxygenation of the eye. If complete detachment of the posterior vitreous can be achieved it might be possible to further slow the progression of diabetic retinopathy.

CONCLUSIONS

It is possible that in the future manipulation of the vitreous by means of enzymes and lasers can play a role in the treatment and prevention of diabetic retinopathy.

摘要

未标注

近年来,玻璃体在糖尿病视网膜病变的各个方面发挥作用已变得明显。然而,玻璃体的确切作用在许多方面仍不明确。玻璃体存在结构变化,例如玻璃体液化和玻璃体后脱离,这些与糖尿病视网膜病变的发生和更早发病相关。此外,玻璃体中存在血管生成和血管抑制因子,它们通过内皮细胞增殖影响新生血管形成。视网膜光凝可导致结构变化(玻璃体后脱离)和组织学变化(玻璃体细胞活性增加),这可防止增殖性糖尿病视网膜病变的进展。玻璃体切除术在预防增殖性糖尿病视网膜病变中的作用通常被认为与去除玻璃体支架有关。但玻璃体切除术也可引起眼部氧合变化。如果能实现玻璃体后完全脱离,可能进一步减缓糖尿病视网膜病变的进展。

结论

未来通过酶和激光对玻璃体进行操作可能在糖尿病视网膜病变的治疗和预防中发挥作用。

相似文献

1
[Role of the vitreous body in diabetic retinopathy].[玻璃体在糖尿病视网膜病变中的作用]
Klin Monbl Augenheilkd. 1993 Nov;203(5):319-23. doi: 10.1055/s-2008-1045684.
2
[Surgical treatment of diabetic retinopathy].[糖尿病视网膜病变的外科治疗]
Bull Soc Belge Ophtalmol. 1995;256:105-12.
3
Management of proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的管理
Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56.
4
[Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy. Surgical treatment of a series of 22 cases].[糖尿病性视网膜病变中后玻璃体膜收缩引起的黄斑水肿。22例系列手术治疗]
J Fr Ophtalmol. 1993;16(11):602-10.
5
[Pars plana vitrectomy in proliferative diabetic retinopathy].[增殖性糖尿病视网膜病变的玻璃体切除术]
Klin Monbl Augenheilkd. 1986 Apr;188(4):283-7. doi: 10.1055/s-2008-1050630.
6
Surgical management of the late complications of proliferative diabetic retinopathy.增生型糖尿病视网膜病变晚期并发症的手术治疗。
Eye (Lond). 2010 Mar;24(3):441-9. doi: 10.1038/eye.2009.325. Epub 2010 Feb 5.
7
[Vitrectomy for diabetic macular edema associated with hyaloid posterior traction].[玻璃体切除术治疗与玻璃体后皮质牵引相关的糖尿病性黄斑水肿]
Bull Soc Belge Ophtalmol. 2000;276:43-8.
8
[Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].[增殖性糖尿病视网膜病变的玻璃体切除术。手术操作的术前因素及术后结果]
Fortschr Ophthalmol. 1990;87(5):443-8.
9
[Cryocoagulation in therapy of proliferative diabetic retinopathy].[冷冻凝固术在增殖性糖尿病视网膜病变治疗中的应用]
Klin Monbl Augenheilkd. 1997 Mar;210(3):147-52. doi: 10.1055/s-2008-1035034.
10
Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.纤溶酶辅助玻璃体切割术治疗糖尿病性黄斑水肿时所切除的内界膜的超微结构
Ophthalmology. 2004 Feb;111(2):231-7. doi: 10.1016/j.ophtha.2003.06.001.

引用本文的文献

1
Emerging liposomal therapies for diabetic retinopathy: a review of novel targeting approaches and advances in retinal health outcomes.用于糖尿病视网膜病变的新兴脂质体疗法:新型靶向方法及视网膜健康结局进展综述
Drug Deliv. 2025 Dec;32(1):2509973. doi: 10.1080/10717544.2025.2509973. Epub 2025 May 29.
2
WF SS-OCTA for detecting diabetic retinopathy and evaluating the effect of photocoagulation on posterior vitreous detachment.应用 WF SS-OCTA 检测糖尿病视网膜病变并评估光凝对玻璃体后脱离的疗效。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1029066. doi: 10.3389/fendo.2022.1029066. eCollection 2022.
3
Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
糖尿病性黄斑水肿患者房水中的基质金属蛋白酶-1和基质金属蛋白酶-9
PLoS One. 2016 Jul 28;11(7):e0159720. doi: 10.1371/journal.pone.0159720. eCollection 2016.
4
Prevalence of myopia and its association with diabetic retinopathy in subjects with type II diabetes mellitus: A population-based study.2型糖尿病患者近视的患病率及其与糖尿病视网膜病变的关联:一项基于人群的研究。
Oman J Ophthalmol. 2012 May;5(2):91-6. doi: 10.4103/0974-620X.99371.
5
Intravitreal gas injection for the treatment of diabetic macular edema.玻璃体内注射气体治疗糖尿病性黄斑水肿。
Clin Ophthalmol. 2011;5:1543-8. doi: 10.2147/OPTH.S25348. Epub 2011 Oct 26.